Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway/Experiment 6/Signature 1
From BugSigDB
Reviewed Marked as Reviewed by Atrayees on 2023-7-14
Source: supp fig 2
Description: Bar plot of compositional differences at species level in the Vanc vs.Coli groups of mice before PD-1 antibody treatment by one-way ANOVA.
Abundance in Group 1: increased abundance in Vanc
Revision editor(s): Mary Bearkland
